Episode 6: Dignity Starts With Us: Rewriting the Dominant Narratives of Substance Use
In this episode, Meghann Perry and Dr. Dani Snyder-Young explore how internalized shame shapes personal and public storytelling, influencing care access and policy. They discuss research and applied storytelling techniques that shift the dominant narrative, promoting dignity and inclusion for people with lived and living experience of substance use. By embracing strength-based storytelling, we can […]
Session 2 – Stigma and Substance Use: Rewriting the Narrative: Overcoming SUD Stigma in Appalachia
This episode explores the unique challenges faced by individuals with substance use disorder (SUD) in Appalachia, focusing on the ways stigma and healthcare access impact SUD outcomes in these communities. Starting with an examination of the historical events and media portrayals that have shaped perceptions of Appalachia, the episode highlights the key social, economic, and political drivers behind the SUD crisis in this region. Drawing from recent research and personal experience caring for this population, Kate Roberts, MA, MSW, LCSW in conversation with Dr. Devin Oller and Kayla Strother, MSN, AGPCNP-C share strategies for addressing stigma and delivering effective care for people living with SUD in Appalachia.
Session 1 – Stigma and Substance Use: Rewriting the Narrative: Learning from Hamsterdams: How Zoning, Real Estate, and Public Policy Create Drug Containment Zones
Many cities, and especially cities with high real estate prices, have clearly defined zones in which public drug use and sales are implicitly tolerated while more stringent enforcement continues everywhere else. Given that addiction services (like methadone clinics or residential programs) are often mobilized to serve these zones and/or deliberately segregated to remain within them–what should our relationship to these zones be as addiction care providers? The podcast will explore the challenges, problems, and opportunities these zones can create for people who use drugs and the providers who care for them.
Federal Guidelines for Opioid Treatment Programs (2024)
This manual provides guidelines for operating an opioid treatment program. It covers patient-centered care planning, assessment, admission, and monitoring; medication administration and use; medical and clinical provisions and practices; certification and accreditation; and the importance of practitioner judgment in providing care.
Opioid Use Disorder, Shared Decision-Making – Patient and Clinician Toolkits
Shared decision-making (SDM) involves a collaborative discussion between the patient and clinician about treatment options, advantages and disadvantages, and helps to identify the optimal treatment based on patient-specific needs and goals.and helps to identify the optimal treatment based on patient-specific needs and goals.
Stimulant Use Disorder, Shared Decision-Making – Patient and Clinician Toolkits
Shared decision-making (SDM) involves a collaborative discussion between the patient and clinician about treatment options, advantages and disadvantages, and helps to identify the optimal treatment based on patient-specific needs and goals.
Navigating Adolescent Development: A Community Session with Child Psychiatrists
Free on-demand webinar! Gain valuable insights into the latest trends and treatments in adolescent development and mental wellness.
The Mental Health & Substance Use Disorder Parity Task Force – Final Report
Practical Guide for Implementing a Trauma-Informed Approach
SAMHSA has issued a Practical Guide for Implementing a Trauma-Informed Approach. Practical Guide for Implementing a Trauma-Informed Approach | SAMHSA The guide specifically focuses on tools and strategies for implementing a TIA. This guide highlights the need for organizational assessment of readiness and capacity before implementing TIA and describes strategies for such assessments. The guide describes implementation strategies across the following 10 domains: Training and Workforce Development; Governance and Leadership; Cross Sector Collaboration; Financing; Physical Environment; Engagement and Involvement; Screening, Assessment, and Treatment Services; Progress Monitoring and Quality Assurance; Policy; and Evaluation. The guide is intended for anyone involved in organization-level change, including practitioners, state and local officials, policy makers, federal and non-federal funders, peers, and family members.
Digital Therapeutics for Prevention, Management, and Treatment in Behavioral Health
This advisory describes digital therapeutics (DTx) and their use in behavioral health, and benefits of DTx in the prevention, management, and treatment of behavioral health conditions.